(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.15%) $82.51
(1.33%) $2.06
(-0.53%) $2 345.30
(-1.05%) $27.37
(-0.08%) $960.70
(0.18%) $0.934
(0.27%) $11.01
(0.11%) $0.797
(0.01%) $93.31
Live Chart Being Loaded With Signals
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases...
Stats | |
---|---|
今日成交量 | 2.38M |
平均成交量 | 0.00 |
市值 | 942.77M |
EPS | $0 ( 2023-05-03 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 39.73 |
ATR14 | $0.0580 (0.39%) |
音量 相关性
Amryt Pharma plc 相关性 - 货币/商品
Amryt Pharma plc 财务报表
Annual | 2021 |
营收: | $222.54M |
毛利润: | $116.42M (52.32 %) |
EPS: | $-0.573 |
FY | 2021 |
营收: | $222.54M |
毛利润: | $116.42M (52.32 %) |
EPS: | $-0.573 |
FY | 2020 |
营收: | $182.61M |
毛利润: | $63.58M (34.82 %) |
EPS: | $-3.30 |
FY | 2019 |
营收: | $58.12M |
毛利润: | $16.12M (27.74 %) |
EPS: | $-4.30 |
Financial Reports:
No articles found.
Amryt Pharma plc
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。